Literature DB >> 7812569

Response to acute ozone exposure in healthy men. Results of a screening procedure.

G G Weinmann1, S M Bowes, M W Gerbase, A W Kimball, R Frank.   

Abstract

We screened 64 healthy, nonsmoking men, 18 to 35 yr old, for their sensitivity to 0.35 ppm ozone (O3) administered for 130 to 150 min with intermittent exercise. The changes in FVC, FEV1, AND FEF25-75 (p < 0.0001) immediately after O3 exposure varied widely among subjects. Histograms of the percentage changes in FVC and FEV1 did not differ from a unimodal, skewed (gamma) distribution (p = 0.99 and p = 0.17, respectively); the changes in FEF25-75 tended to deviate from a gamma distribution (p = 0.055). To adjust FEF25-75 for the confounding effects of O3 on FVC, we used multiple linear regression analysis with contemporaneous FVC as a covariable, analysis of a subgroup of nine subjects whose O3-induced FVC changes were < or = 5%, and volume correction of FEF25-75 for any changes in FVC after exposure. These analyses showed reductions in FEF25-75 unexplained by and following a different time course than the O3-induced changes in FVC. In 26 subjects also exposed to filtered air, significant effects of O3 on respiratory frequency (p < 0.004) and tidal volume (p < 0.0007) correlated weakly with FVC changes. The results confirm the wide variability in spirometric responsiveness among individuals to O3 and suggest that intrinsic narrowing of the small airways may be a significant component of the functional response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7812569     DOI: 10.1164/ajrccm.151.1.7812569

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

Review 1.  Environmental contributions to allergic disease.

Authors:  E Levetin; P Van de Water
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

Review 2.  Progression of allergy and asthma through childhood to adolescence.

Authors:  E von Mutius
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 3.  Air pollution: brown skies research.

Authors:  A E Tattersfield
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 4.  Ozone and pulmonary innate immunity.

Authors:  John W Hollingsworth; Steven R Kleeberger; W Michael Foster
Journal:  Proc Am Thorac Soc       Date:  2007-07

Review 5.  Macrophage phagocytosis: effects of environmental pollutants, alcohol, cigarette smoke, and other external factors.

Authors:  John Karavitis; Elizabeth J Kovacs
Journal:  J Leukoc Biol       Date:  2011-08-30       Impact factor: 4.962

Review 6.  Toxicogenetics: population-based testing of drug and chemical safety in mouse models.

Authors:  Ivan Rusyn; Daniel M Gatti; Timothy Wiltshire; Timothy Wilshire; Steven R Kleeberger; David W Threadgill
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

7.  Is there an association between lifetime cumulative exposure and acute pulmonary responses to ozone?

Authors:  Mehrdad Arjomandi; Ira B Tager; Maria Bastaki; Connie Chen; Nina Holland; John R Balmes
Journal:  J Occup Environ Med       Date:  2008-03       Impact factor: 2.162

8.  Ozone exposure, antioxidant genes, and lung function in an elderly cohort: VA normative aging study.

Authors:  S E Alexeeff; A A Litonjua; R O Wright; A Baccarelli; H Suh; D Sparrow; P S Vokonas; J Schwartz
Journal:  Occup Environ Med       Date:  2008-06-04       Impact factor: 4.402

Review 9.  Oxidants and the pathogenesis of lung diseases.

Authors:  Jonathan Ciencewicki; Shweta Trivedi; Steven R Kleeberger
Journal:  J Allergy Clin Immunol       Date:  2008-09       Impact factor: 10.793

10.  The role of the extracellular matrix protein mindin in airway response to environmental airways injury.

Authors:  Sarah Frush; Zhuowei Li; Erin N Potts; Wanglei Du; Jerry P Eu; Stavros Garantziotis; You-Wen He; W Michael Foster; John W Hollingsworth
Journal:  Environ Health Perspect       Date:  2011-06-17       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.